You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 8, April 27, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Complementary and Alternative Medicine
 •Treatment Adherence
 •Quality of Care
 •Quality of Care, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Hospital Admissions Related to Medications and Implementing Guidelines

Peter A. G. M. De Smet, PharmD, PhD; for the HARM-Wrestling Group

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The investigation by Leendertse et al1 confirms earlier findings that many hospital admissions related to medications (HARMs) are potentially preventable and that a substantial portion of them involve a handful of long-existing drug classes with pharmacologically predictable effects. The important implication is that clinical risk management should focus not only on new risks of new drugs but also on certain old risks of old drugs. This prompted the setup of an expert "HARM-Wrestling" Group, which has recently presented specific advice concerning 7 categories of adverse effects (ie, hemorrhage, electrolyte disturbances, fractures, disturbances of diabetic control, renal insufficiency and heart failure, constipation, and bradycardia).2

Roughly speaking, half of the advice is about appropriate prescribing (eg, giving drugs only on strict indication or adding a protective drug), a quarter is about careful follow-up (eg, laboratory monitoring and appropriate duration of . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Hospital Admissions Related to Medications and Implementing Guidelines—Reply
Patricia M. L. A. van den Bemt, Anne J. Leendertse, Lennart J. Stoker, and Antoine C. G. Egberts
Arch Intern Med. 2009;169(8):811.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.